-
Medtronic's spine business sees slight revenue uptick in Q3: 6 notes
Medtronic saw increases in its worldwide revenue and neuroscience sales during the third quarter of fiscal year 2022, according to financial results posted Feb. 22. -
Orthopedic devicemaker, Brainlab partner to develop navigation instruments
Safe Orthopaedics has partnered with Brainlab to create navigable surgical tools, the devicemaker said Feb. 21. -
Gramercy Extremity Orthopedics gets clearance for plating systems
Gramercy Extremity Orthopedics' distal fibular ankle fracture plating system and multi-application extremity plating system received FDA approval, the devicemaker said Feb. 21. -
Globus Medical's revenue rises 7.1% in Q4: 5 notes
Globus Medical saw $250 million in sales in the fourth quarter of 2021 and $958.1 million in full-year sales, according to financial results posted Feb. 17. -
2 devicemakers raise $75M to launch products in US
In the last week, two European spine devicemakers raised a total of $75.6 million in capital to launch products in the U.S. -
Nexus Spine appoints sales exec
Devicemaker Nexus Spine named Steve Cichy as vice president of sales, according to a Feb. 17 news release. -
Swiss spine company raises $20.6M to support augmented-reality platform
Switzerland-based devicemaker Neo Medical landed $20.6 million in funding to support the U.S. launch of an augmented reality spine system. -
DePuy Synthes' new buy, Forbes' best medtech employers and more: 5 device company notes
Two orthopedic devices debut, and three more updates from spine and orthopedic medtech companies in the last week: -
Federal judge narrows surgeon's patent lawsuit against SeaSpine
A Delaware district court judge has partially dismissed a spine surgeon's patent lawsuit against SeaSpine. -
Spinal implant company raises $55M, eyes US launch of 2 devices
France-based devicemaker Companion Spine raised $55 million in series A funding and plans to launch two products in the U.S. in 2023. -
Stryker vs. Zimmer Biomet vs. J&J: How they stack up in Q4
Stryker, Zimmer Biomet and Johnson and Johnson shared their financial results for the fourth quarter of 2021. -
7 spine devices got FDA approval in January
The FDA cleared seven spine devices last month. -
4 device companies honored on Forbes' best large employers list
Forbes released its 2022 list of America's best large employers Feb. 10 and recognized four medical device companies. -
DePuy Synthes buys orthopedic medtech company
DePuySynthes, the orthopedic arm of Johnson & Johnson, acquired CrossRoads Extremity Systems. -
Dr. Ran Schwarzkopf debuts Smith+Nephew's new knee replacement system
Ran Schwarzkopf, MD, of New York City-based NYU Langone Health, completed the first case with Smith+Nephew's Journey II medial dished knee replacement system. -
Spinal posterior fixation system debuts in US
The first cases with Implanet's Jazz posterior fixation system were completed, the devicemaker said Feb. 9. -
ZimVie's $1B sales forecast, Aurora Spine's patent nod and more: 4 device company notes
How Zimmer Biomet performed in the fourth quarter of 2021 and three more updates from spine and orthopedic device companies: -
Implant helps 3 spinal cord injury patients walk again
Swiss researchers have developed an implant that has enabled three patients with complete spinal cord injuries to stand, walk and swim again. -
Virtual reality surgery training platform validated on 5 industry benchmarks
PrecisionOS' virtual reality surgical training platform has met five industry benchmarks for validation, the company said Feb. 8. -
Zimmer Biomet expands partnership with infection control company
Zimmer Biomet and Bactiguard have expanded their global license partnership that was initiated in 2019.
Page 36 of 50